drugset / Trial / NCT03103685

Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.

NCT03103685 ↗

Phase 4 Unknown 428 enrolled Chiang Mai University
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a prospective randomized open-label blinded endpoint (PROBE) The study will be conducted in Maharaj Nakorn Chiang Mai hospital. The patients with dual-antipletlet who need dental procedure between Febuary 2017 until Febuary 2018 will be included in the study. Baseline characteristics of the enrolled patients including bleeding complication will be collected in each patient. To compare rate of significant bleeding from dental procedure between patient who need two antiplatelet and who stop P2Y12 inhibitors before procedure.

Timeline

Start
2017-05-01
Primary completion
2018-12-30
Completion
2018-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule — —

Indications